NIFTY 50▼21,995.85
-152.05 (-0.69%)
SENSEX▼72,488.99
-454.69 (-0.62%)
NIFTY BANK▼47,069.45
-415.35 (-0.87%)
TATA MOTORS▼971.35
-21.45 (-2.16%)
INDIAN RAILWAY FINANCE CORP▲141.95
0.25 (0.18%)
SUZLON ENERGY▲41.15
0.65 (1.60%)
TATA POWER▼429.75
-0.65 (-0.15%)
TATA STEEL160.05
0.00 (0.00%)
YES BANK▼23.90
-0.05 (-0.21%)
INDIAN RENEWABLE ENERGY▲163.15
3.10 (1.94%)
RELIANCE INDUSTRIES▼2,928.65
-2.85 (-0.10%)
RELIANCE POWER▲28.70
1.35 (4.94%)
HDFC BANK▼1,494.70
-14.55 (-0.96%)
RAIL VIKAS NIGAM▲259.90
2.00 (0.78%)
ADANI POWER▼598.10
-3.50 (-0.58%)
VODAFONE IDEA▲13.20
0.25 (1.93%)
JIO FIN SERVICES LTD▲378.40
16.55 (4.57%)
ZOMATO▼185.20
-1.25 (-0.67%)
NHPC▼89.50
-1.70 (-1.86%)
INDIAN RAILWAY TOURISM CORP▼992.95
-23.50 (-2.31%)
STATE BANK OF INDIA▼744.80
-6.90 (-0.92%)
INDIAN OIL CORP169.00
0.00 (0.00%)
MRF▼1,29,231.50
-924.65 (-0.71%)
ITC▼418.85
-7.05 (-1.66%)
ADANI GREEN ENERGY▼1,775.45
-36.20 (-2.00%)
ADANI ENTERPRISES▼3,019.30
-87.10 (-2.80%)
JAIPRAKASH POWER VENTURES17.20
0.00 (0.00%)
ADANI PORT & SEZ▼1,295.55
-8.80 (-0.67%)
Suven Pharmaceuticals Share Price
SUVENPHAR
₹650.40+₹16.10 (2.54%) Past YearLast updated on 18 Apr, 2024 | 03:29 PM IST
₹626.50₹653.90
LH
What’s in news?
Company overview
About
Market cap
| Open₹643.05 | Close₹634.30 |
Circuit range₹761.15 - ₹507.45 | Day range₹626.50 - ₹653.90 | Year range₹463.40 - ₹768.00 |
Volume1,72,913 | Avg. traded₹644.30 | Revenue (12m)₹1,168 Cr |
Suven PharmaceuticalsSuven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.
Read more
Suven Pharmaceuticals Key indicators
52 week high₹768.00 | 52 week low₹463.40 | P/E ratio43.52 |
P/B ratio8.12 | ROE26.46% | ROCE34.48% |
Dividend yield0.95% | Debt/Equity ratio0.04 | EPS16.99 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin47.7% | Net profit margin32.5% |
ROE26.46% | ROA21.39% |
ROCE34.48% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Suven Pharmaceuticals Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Tue, Apr 16 2024 | ₹622.00 | ₹634.30 | |
Mon, Apr 15 2024 | ₹621.00 | ₹627.60 | |
Fri, Apr 12 2024 | ₹616.00 | ₹625.60 | |
Wed, Apr 10 2024 | ₹631.95 | ₹615.65 | -2.65% |
Tue, Apr 9 2024 | ₹628.35 | ₹631.00 | |
Mon, Apr 8 2024 | ₹651.10 | ₹628.35 | -3.62% |
Fri, Apr 5 2024 | ₹649.00 | ₹648.20 | -0.12% |
Thu, Apr 4 2024 | ₹666.75 | ₹645.60 | -3.28% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 09 Sep 2022
Dividend • ₹5/share
Ex date 09 Sep 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 15 Feb 2022
Dividend • ₹2/share
Ex date 15 Feb 2022
Learn more